Protein detail

S22A8

Organic anion transporter 3 (hOAT3) (Organic anion/dicarboxylate exchanger) (Solute carrier family 22 member 8)

Entry name
S22A8
UniProt ID
EVMP confidence score
0.38
Supporting publications (n)
Transmembrane count
11
Protein classification
FDA approved drug targetsMetabolic proteinsPredicted membrane proteinsTransporters
EVMP confidence score

Annotation confidence score; open for threshold definitions.

Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
Basic Information12
Protein Names
Organic anion transporter 3 (hOAT3) (Organic anion/dicarboxylate exchanger) (Solute carrier family 22 member 8)
Protein Class (4)
FDA approved drug targetsMetabolic proteinsPredicted membrane proteinsTransporters
Protein Function (2)
  • Transporters:Electrochemical Potential-driven transporters
  • FDA approved drug targets:Small molecule drugs
Transmembrane
10..30; Helical; 124..144; Helical; 155..175; Helical; 177..197; Helical; 213..233; Helical; 237..257; Helical; 328..348; Helical; 355..375; Helical; 387..407; Helical; 412..432; Helical; 472..492; Helical
Transmembrane Count
11
Entrez Gene Symbol
Gene Synonym
OAT3
Gene Description
Solute carrier family 22 member 8
Chromosome
11
Position
62989154-63015841
EVMP confidence score
0.38
Fluorescence & Localization2
Cell SpecificFibro-adipogenic progenitorsSingle-Nuclei Brain Specificoligodendrocyte
Function & Pathway7
Relations & Evidence21

Ligand-Receptor Signaling (20)

20 records.

CategoryParentDatabaseTransmitterReceiverSecretedPlasma Membrane (Transmembrane)Plasma Membrane (Peripheral)
transmembranetransmembraneOmniPathNoNoNoNoNo
plasma_membraneplasma_membraneUniProt_locationNoNoNoNoNo
basolateral_cell_membraneplasma_membraneUniProt_locationNoNoNoNoNo
basolateral_cell_membraneplasma_membraneRamilowski_locationNoNoNoNoNo
plasma_membraneplasma_membraneRamilowski_locationNoNoNoNoNo
plasma_membraneplasma_membraneOmniPathNoNoNoNoNo
cell_surfacecell_surfaceSurfaceomeNoNoNoNoNo
cell_surfacecell_surfaceOmniPathNoNoNoNoNo
receptorreceptorscConnectNoYesNoNoNo
transmembranetransmembrane_predictedPhobiusNoNoNoNoNo
Page 2 of 2Previous

Isolation & Detection Technology (1)

1 record.

EV Isolation MethodDetection MethodNumber of ReferencesReferences
Differential UltracentrifugationUltrafiltration / Tangential Flow FiltrationSize Exclusion ChromatographyImmunoaffinity CaptureMass spectrometry143371834237862381389386743994949026538482315085003887173037702715327954143007131837033249376863664009834633114768
Sequence, Structure & Domains9

Sequences

Length
542
Mass
59,856
Sequence
MTFSEILDRVGSMGHFQFLHVAILGLPILNMANHNLLQIFTAATPVHHCRPPHNASTGPWVLPMGPNGKPERCLRFVHPPNASLPNDTQRAMEPCLDGWVYNSTKDSIVTEWDLVCNSNKLKEMAQSIFMAGILIGGLVLGDLSDRFGRRPILTCSYLLLAASGSGAAFSPTFPIYMVFRFLCGFGISGITLSTVILNVEWVPTRMRAIMSTALGYCYTFGQFILPGLAYAIPQWRWLQLTVSIPFFVFFLSSWWTPESIRWLVLSGKSSKALKILRRVAVFNGKKEEGERLSLEELKLNLQKEISLAKAKYTASDLFRIPMLRRMTFCLSLAWFATGFAYYSLAMGVEEFGVNLYILQIIFGGVDVPAKFITILSLSYLGRHTTQAAALLLAGGAILALTFVPLDLQTVRTVLAVFGKGCLSSSFSCLFLYTSELYPTVIRQTGMGVSNLWTRVGSMVSPLVKITGEVQPFIPNIIYGITALLGGSAALFLPETLNQPLPETIEDLENWSLRAKKPKQEPEVEKASQRIPLQPHGPGLGSS
Alternative Products
Event=Alternative splicing; Named isoforms=5; Name=1; IsoId=Q8TCC7-1; Sequence=Displayed; Name=2; IsoId=Q8TCC7-2; Sequence=VSP_022565; Name=5; IsoId=Q8TCC7-5; Sequence=VSP_045824; Name=3; IsoId=Q8TCC7-3; Sequence=VSP_022562, VSP_022563, VSP_022564; Name=4; IsoId=Q8TCC7-4; Sequence=VSP_045272
Alternative Sequence
1..345; Missing (in isoform 3); 1..123; Missing (in isoform 5); 1..91; Missing (in isoform 4); 406..455; DLQTVRTVLAVFGKGCLSSSFSCLFLYTSELYPTVIRQTGMGVSNLWTRV -> GERLGLPQNPLEEAARLGARDFTAGSASKSLCYLEQVPALSGAQGLSSRK (in isoform 3); 456..542; Missing (in isoform 3); 510; W -> WSVTASGPPR (in isoform 2)

Domain & Motif Annotations

Compositional Bias
517..527; Basic and acidic residues
Region
515..542; Disordered
Protein Families (2)
  • Major facilitator (TC 2.A.1) superfamily
  • Organic cation transporter (TC 2.A.1.19) family
Sequence Similarities
Belongs to the major facilitator (TC 2.A.1) superfamily. Organic cation transporter (TC 2.A.1.19) family.
Clinical Relevance6